Michael Phalen, acting executive vice president and president-MedSurg of Boston Scientific, recently sold 35,000 shares of the firm, according to a Franklin Independent report.
Here are three notes:
1. The total transaction was valued at $770,000, at an average stock price per share of $22.
2. The highest price target for the stock is $26 and the lowest is $19.
3. The company has a market cap of $32.87 billion.